baber/WOPTO huggingface dataset:
Patent MD-20040241-A (MD)
Title: Method and device for multiplication by constant in the Galois field
Inventor: BODEAN GHENADIE
IPC: G06F7/00
Filed: 2004-09-28
Abstract: The invention relates to the Galois field (GF) arithmetic, in particular to the multiplication of two elements of the GF filed, one of which is a constant.The aim of the invention is optimization of the calculations in the Galois field of the expense of exclusion of the surplus intermediate operations.Summary of the method of multiplication according to the module of polynomial g(x) of two elements A and C of the Galois field GF(2m), where the degree of irreducible polynominal g(x) is equal to m, where m is positive integral number, A=(a0,…,am-1), and the arbitrary element of the GF(2m) field with the bits aiЄ{0,1}, i=0,…,m-1, C=(c0,…,cm-1) is the constant of the GF(2m) field with the fixed value of the bits ci, where ci=0 or 1, in order to obtain a third element B of the GF(2m) field, where B=(b0,…,bm-1), bjЄ{0,1}, j=0,…,m-1, consists in the m-time interactive execution of the following group of operations: the bit ai is multiplied in those intermediate positions j for which its value corresponds to cj, the constant C is equal to 1, the constant C is multiplied by 2, according to the module of polynomial g(x). The bits ai converging in the same position j, are summed over the module 2, being obtained as a result the logic value 0 or 1 of the corresponding bit bj of the A element product to the C constant. If in the position j there is converged only one input bit ai, then the output bit bj takes the value of the bit ai.
Patent MD-20070287-A (MD)
Inventor: TORRIJOS MICHEL
IPC: C02F3/28
Filed: 2006-04-27
Abstract: Inventia se refera la un procedeu de epurare a apelor reziduale intr-un reactor anaerob (1), in care microorganismele sunt fixate pe suporturi, totodata suporturile formeaza un strat imobil, fixat inuna din partile (4, 5) reactorului. Procedeul se caracterizeaza prin aceea ca la colmatarea reactorului, cel putin partial, el se curata prin suspendarea temporara a suporturilor. Un avantaj al procedeului consta in aceea ca la etapa initiala de demarare a reactorului marirea incarcaturii se produce la un timp de retentie hidraulica scurt si constant.
Patent MX-154225-A (MX)
Inventor: BRACONIER KARL
IPC: F16J15/32
Filed: 1981-02-04
Abstract: A hydrodynamic shaft seal for use under both static and dynamic conditions features a sealing face having one static sealing surface at the non-liquid side of the seal and a dynamic sealing surface having a plurality of angular vanes forming chambers open to the liquid at the liquid side of the seal. An annular coil spring biases the static sealing surface into contact with the shaft under static conditions and controls its spacing under dynamic conditions during which the vanes propel liquid toward the liquid side of the seal.
Patent NZ-204523-A (NZ)
Title: Vaginally applied contraceptive composition containing styrene polymer salt
Inventor: SZYMANSKI C D
IPC: A61K31/745
Filed: 1983-06-10
Abstract: A contraceptive composition for vaginal administration which contains a salt of a sulfonated styrene polymer and a pharmaceutically acceptable carrier. Effective polymers have a degree of substitution of from about 0.7 to 1.3 and an average molecular weight of between 600 and 7,000,000.
Patent NZ-209268-A (NZ)
Title: Introducing prokaryotic organisms into eukaryotic plant cells
Inventor: PATON A M
IPC: C12N15/00
Filed: 1984-08-17
Abstract: Associations of prokaryotic organisms and eukaryotic plant cells are produced by bringing bacteria and an L-form inducer into contact with the plant cell or by bringing the cell into contact with liquid obtained from plant cells containing the prokaryotic organism. Aqueous suspensions of L-form bacteria passed through a bacterial filter may be used to treat plant cells.
Patent NZ-215908-A (NZ)
Title: Preparation of antiadhesins and products so prepared
Inventor: RAYJOND J
IPC: A23L29/00
Filed: 1986-04-22
Abstract: 1. A process for the preparation of cell adhesion inhibitors, or antiadhesins, which process is characterized in that the glycoproteins and/or the glycopeptides, the lipid structures and/or the glycolipids contained in or originating from different liquid or solid organic substrates are enzymatically and/or chemically lyzed and in that the structures resistant to lysis, which are of partially or totally osidic character and whose molecular weight is always greater than 1000, are collected and sterilized.
Patent NZ-218179-A (NZ)
Title: Compositions which include a hydroxyalkyl phosphine compound for control of bryophytes, lichens, algae and fungal and microbial plant pathogens
Inventor: TALBOT R E
IPC: A01N57/34
Filed: 1986-11-05
Abstract: Hydroxyalkyl phosphine compounds such as tetrakis (hydroxymethyl) phosphonium salts are used to control bryophytes, lichens algae or fungal or microbial plant pathogens.
Patent NZ-218625-A (NZ)
Title: Ankle brace: first and second aircells in overlapping juxtaposition provide resilient cushion
Inventor: JOHNSON GLENN W
IPC: H01H3/58
Filed: 1986-12-15
Abstract: A pneumatic brace comprising at least one outer shell member and at least first and second pressurizable chambers juxtaposed therewith in an overlapping manner for providing a supporting cushion between said outer shell member and a body part or limb. One of said chambers is coextensive with substantially the entire inner surface of said one outer shell member for engagement with a corresponding portion of said body part or limb, while the other of said chambers is coextensive with a portion of said first chamber. In one preferred embodiment, the first and second chambers comprise separate inflatable airbags of different size disposed on said outer shell member with the smaller airbag positioned coextensively with the bottom portion of the larger airbag and between said larger airbag and said inner surface of said outer shell member. In alternatively preferred embodiments, the first and second chambers are integrally formed from a single inflatable liner having two compartments divided by a common wall, at least one of said compartments being selectively inflatable through integral valve means formed at least in part by said common wall.
Patent NZ-223463-A (NZ)
Title: Stabilised untanned hides
Inventor: GAVEND G
IPC: C14C3/00
Filed: 1988-02-09
Abstract: These hides, completely free from chromium, have a moisture content of between 15 and 20%, a maximum inorganic matter content of 10 +/- 2%, an aluminium oxide content of 0.7 +/- 0.2% and an acrylic derivatives content of approximately 2%. Their pH is in the region of 4.0% and their dermic substance content is approximately 85 +/- 3%. They are capable of being rewetted in less than an hour. The process for obtaining them, of the type consisting in subjecting the completely delimed and bated hides to a pickling treatment in the presence of acrylic resin and then, after a rest, to a pretanning treatment with the aid of aluminium salts, is characterised in that there is introduced at any stage of the treatment a chemical agent facilitating the rewetting and enabling the hide to retain, after drying, a residual moisture close to 20% and in that the hide thus treated is subjected to drying. This chemical agent is chosen from the group consisting of polyalcohols, condensates of fatty alcohols with ethylene oxide and condensates of alkylphenols with ethylene oxide.
Patent NZ-228632-A (NZ)
Title: Topical otopathic preparations containing ofloxacin
Inventor: KIICHI SATO
IPC: A61K31/535
Filed: 1989-04-06
Abstract: The use of ofloxacin or a salt thereof for preparing a topical preparation for treating otopathy is disclosed.
Patent NZ-228807-A (NZ)
Title: Compression of run length and colour encoded video data
Inventor: MUSIC JOHN
IPC: G06T9/00
Filed: 1989-04-19
Abstract: The method and system for compressing color video data in a video communication system utilizes a three color digital signal, and involves the determination of a luminance function for each pixel in a series of video picture frames. One or more decision parameters based upon differences of the luminance function between pixels are compared with corresponding adaptive thresholds to determine decision points in the scan lines, and the digital word size of the three digital color components is reduced before encoding of run lengths between decision points of the color values.
Patent NZ-245343-A (NZ)
Title: Use of gamma-linolenic acid (or the dihomoequivalent) in a method of inhibiting the reocclusion of an unblocked artery
Inventor: HORROBIN DAVID FREDERICK
IPC: C07C57/12
Filed: 1992-12-02
Abstract: Gamma-linolenic acid and/or dihomo-gamma-linolenic acid is used in the preparation of a medicament for inhibiting occlusion of peripheral or coronary arteries. The medicament may also comprise eicosapentaenoic acid.
Patent NZ-274849-A (NZ)
Title: Benzoyl guanidine derivatives, preparation and pharmaceutical compositions thereof
Inventor: ROOS OTTO DIPL CHEM DR
IPC: C07D213/74
Filed: 1994-10-31
Abstract: PCT No. PCT/EP94/03581 Sec. 371 Date Aug. 9, 1996 Sec. 102(e) Date Aug. 9, 1996 PCT Filed Oct. 31, 1994 PCT Pub. No. WO95/12584 PCT Pub. Date May 11, 1995New compounds of general formula (I) are provided:    <IMAGE>  (I)  which are explained in the specification can be prepared by a variety of methods. The compounds may be used in pharmaceutical compositions.
Patent NZ-282381-A (NZ)
Title: Conditioning liquid samples containing fat globules and somatic cells or protein particles prior to flourescent measurements to determine bacterial content
Inventor: AEGIDIUS POUL ERIK
IPC: C12Q1/04
Filed: 1995-03-16
Abstract: PCT No. PCT/DK95/00119 Sec. 371 Date Sep. 16, 1996 Sec. 102(e) Date Sep. 16, 1996 PCT Filed Mar. 16, 1995 PCT Pub. No. WO95/25174 PCT Pub. Date Sep. 21, 1995A method is disclosed for conditioning samples (of e.g. milk or meat) containing fat globules and somatic cells and/or protein particles before they are subjected to fluorescence measurements in order to determine the bacterial content, as well as methods for performing the determination of bacterial content in such samples. The conditioning method involves the treatment of the samples with an ion-chelating agent, a proteolytic enzyme, detergent, and a bacteriologically specific fluorochrome such as ethidium bromide. Detergent is used in a concentration resulting in substantially no dissolution of the fat globules and the conditioned samples thus loses insignificant amounts of fat globules. The assessment of fluorescence is preferably performed in a conventional flow cytometer. As no separation of fat globules is necessary, the methods are simple and fast. The bacterial determinations have proved reliable when compared to standard methods.
Patent NZ-286273-A (NZ)
Title: Dishwasher - rotor of electric motor mounted within a well in the chamber floor and stator mounted circumferentially about the exterior surface of the well
Inventor: SARGEANT ADRIAN ANTHONY
IPC: A47L15/23
Filed: 1992-12-18
Abstract: A dishwasher comprising: a wash chamber adapted to accommodate dishes and within which wash liquid is circulated, a rack within said chamber which supports dishes above the floor of said chamber, a rotatable spray arm having liquid discharge nozzles located in the bottom of said wash chamber under said rack, a pump which pressurises said spray arm with wash liquid, and mounting means located centrally in the floor of said chamber which rotatably supports said spray arm, said spray arm in turn comprising a hub portion and two diametrically opposed wing portions extending outwardly therefrom towards the side walls of said chamber, and said wing portions shaped such that they droop downwardly away from the hub portion.
Patent NZ-286709-A (NZ)
Title: Papermaking woven dryer fabric with paper contact surface having polyurethane-based hydrophillic substance
Inventor: FAGERHOLM LARS
IPC: D21F7/08
Filed: 1996-05-31
Abstract: The invention relates to a dryer fabric (V) for use in a dryer section (C1-C3) having a closed transfer in a papermaking machine. The dryer fabric has a structure woven of threads, one side, called the paper side, being adapted to support and abut against a paper web (B) in the dryer section. At least some of the thread contact surfaces which are positioned on the paper side of the dryer fabric (V) and which during operation of the dryer fabric abut against the paper web (B) are hydrophilic, thereby obtaining adhesion between the dryer fabric and the paper web. <IMAGE>
Patent NZ-289105-A (NZ)
Title: Container and screw cap with an outer foil cover, projections on the closure pierce the cover when the closure is unscrewed
Inventor: GILES GEOFFREY ALAN
IPC: B65D41/04
Filed: 1995-06-19
Abstract: A container, suitable for pourable fluids such as beverages, has a closure 16 which is rotated relative to the container for opening and an outer foil cover 19, the foil cover extending beyond the edge of the closure to lie against the container wall and the closure having one or more projections 20 that puncture or weaken the foil cover on rotation of the closure. The projections preferably provide a serrated edge of castellated shape (figure 4). The closure may fit directly on the container neck or on an adapter 14 fastened on the neck. The closure may engage the neck/adapter by screw threads or by way of cooperating cam surfaces. <IMAGE>
Patent NZ-296044-A (NZ)
Title: Wholegrain food products - snack foods, crisp-bread, breakfast cereals or confectionery containing 20 - 100% wholegrains of a waxy character
Inventor: LEWIS VICTOR MARCUS
IPC: A23L7/165
Filed: 1995-11-29
Abstract: Processes for producing wholegrain food products are described. Wholegrains comprising 20 % to 100 % waxy grains are cooked in the presence of moisture so as to gelatinize the grains. The gelatinized grains are formed into a dough of suitable size and shape, dried to a water content from about 4 % to about 25 %, and thereafter expanded by heating. Also described are food products produced by these processes.
Patent NZ-333259-A (NZ)
Title: Vector for introducing desired gene with selectable marker which allows the desired gene to be removed by removal of the selectable marker (anchor selectable marker gene)
Inventor: SUGITA KOICHI
IPC: C12N15/84
Filed: 1997-05-09
Abstract: The present invention relates to a vector for introducing a desired gene into a plant, wherein a selectable marker gene introduced into a plant cell along with a desired gene is optionally removable from the DNA such as chromosome or the like where it exists and functions, then disappeared the function thereof after its expression, and the expression of the selectable marker gene and the disappearance of the function thereof are detectable by morphological change of the tissue derived from the plant cell into which the selectable marker gene is introduced. Also, the present invention constitutes a vector using a morphological abnormality induction gene as a selectable marker gene, while putting a removable DNA element under control of an inducible promoter, wherein the morphological abnormality induction gene is positioned such that it behaves integrally with the removable DNA element, and wherein a desired gene is positioned such that it does not behave integrally with the removable DNA element.
Patent NZ-334579-A (NZ)
Title: reduced fat agglomerated chocolate having a average particle size of 5mm or less and a fat content of 18-24% by weight
Inventor: DUBBERKE KARIN
IPC: A23L27/60
Filed: 1999-03-10
Abstract: Reduced fat agglomerate chocolate having an average particle size up to 5mm and containing from 18-24% fat, by weight of the chocolate and chocolate products made thereof.
Patent NZ-335460-A (NZ)
Title: Software producing method, processor, processing method and recording medium
Inventor: NEGORO FUMIO
IPC: G06F9/44
Filed: 1997-04-30
Abstract: Firstly, definitive identifiers are determined, which are the screen needed for the software to be produced. Next, words existing in the definitive identifier are sorted out, as well as the homogeneity map is created where all pallets needed for the software are placed according to the process flow based on the definitive identifier. Next, the necessary file is determined based on the sorted-out words and the created homogeneity map. Next, the following tense control vectors are created: the first tense control vector that implements screen editing or file editing for all the sorted-out words; the second tense control vector that determines the homogeneity route for all the sorted-out words; and the third tense control vector that implements file updating. Next, the three kinds of pallets are created, which are made by binding the first, the second and the third tense control vectors per screen unit, respectively, as well as the pallet function is created, which executes each of the tense control vectors inside each pallet with autonomous significance. The three kinds of the pallet functions are assembled into the pallet chain function with the structure of transmitting a screen based on the pallet function concerned with the first tense control vector, receiving the screen to execute the pallet function concerned with the second tense control vector, and determining, in accordance with this execution result, one homogeneity route from the plural homogeneity routes taking at least one homogeneity route for executing the pallet function concerned with the third tense control vector. Hereupon, with this software, it is not necessary to create tense control vectors for all words, and if tense control vectors are created for a certain number of words, it operates within such scope.
Patent NZ-336684-A (NZ)
Title: 5-aroylnaphthalene derivatives and their use in treating inflammatory and autoimmune disease
Inventor: SJOGREN ERIC BRIAN
IPC: C07C323/22
Filed: 1998-01-21
Abstract: Anti-inflammatory and analgesic compounds, specifically 5-aroylnaphthalene derivatives of formula (I).  A is a bond, -CH2-, -CH(OH)-, -C=NOR4-, -C(O)-, -NR5-, -O-, or -S(O)n- where n is an integer from 0 to 2, R4 is hydrogen or alkyl, and R5 is hydrogen, alkyl, or acyl.  Z is a group represented by formula (B), (C), (D), or (E), where n1 is 0 to 3; X is O or S; R6 and R7 are independently selected from hydrogen, alkyl, halogenalkyl, cycloalkyl, cycloalkylalkyl, acyl, alkylthio, cycloalkylthio, cycloalkylalkylthio, alkoxy, cycloalkyloxy, cycloalkylalkyloxy, halogenalkyloxy, alkenyl, halogen, cyano, nitro, hydroxy, or -NR9R10 where R9 and R10 are independently hydrogen, alkyl, or acyl; or R6 and R7 when they are adjacent to each other form methylenedioxy or ethylenedioxy; R8 is hydrogen, alkyl, halogenalkyl, alkoxy, cycloalkyloxy, halogenalkyloxy, alkylthio, cycloalkylthio, nitro, cyano, hydroxy, or halogen; R1 is hydrogen, alkyl, alkenyl, alkynyl, halogenalkyl, cycloalkyl, cycloalkylalkyl, alkoxy, alkenyloxy, cycloalkyloxy, cycloalkylalkyloxy, halogenalkyloxy, hydroxyalkyloxy, alkoxyalkyloxy, alkylthio, cycloalkylthio, cycloalkylalkylthio, hydroxy, halogen, cyano, carboxy, alkoxycarbonyl, acyl, -C=NOR4, -NR9R10, -CONR9R10, -OCONR9R10, or -OSO2R11 where R4, R9, and R10 are as previously defined and R11 is alkyl, cycloalkyl, or halogenalkyl; R2 is hydrogen, alkyl, alkoxy, halogen, nitro, or -NR9R10; and R3 is -SO2R12 or -SO2NR13R14 where R12 is alkyl, hydroxyalkyl, alkoxyalkyl, carboxyalkyl, or alkoxycarbonylalkyl; R13 is hydrogen, alkyl, or acyl; and R14 is hydrogen, alkyl, halogenalkyl, cycloalkyl, cycloalkylalkyl, alkenyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonylalkyl, amino, aminoalkyl, aryl, aralkyl, heteroaralkyl, heterocyclo, heterocycloalkyl, acyl, hydroxy, or alkoxy; or R13 and R14 together with the nitrogen atom to which they are attached optionally form a heterocycloamino group; that are inhibitors of prostaglandin G/H synthase, pharmaceutical compositions containing them, methods for their preparation and their use in treating inflammatory disease, especially myositis, synovitis, gout, ankylosing spondylitis, bursitis and arthritis preferably rheumatoid arthritis and osteoarthritis, and autoimmune disease, especially systemic lupus erythematosus and type I diabetes. Particularly preferred compounds are: 5-(4-fluorobenzoyl)-6-methoxy-2-naphthalenesulfonamide. 5-(4-methylbenzoyl)-6-methoxy-2-naphthalenesulfonamide. 5-(2-fluorobenzoyl)-6-methoxy-2-naphthalenesulfonamide. 5-(3-fluorobenzoyl)-6-methoxy-2-naphthalenesulfonamide. 5-(4-fluorobenzoyl)-6-methoxy-2-methylsulfonylnaphthalene. 5-(4-fluorobenzoyl)-6-hydroxy-2-methylsulfonylnaphthalene.
Patent NZ-500538-A (NZ)
Title: Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
Inventor: TINTI MARIA ORNELLO
IPC: A23K1/16
Filed: 1998-03-19
Abstract: The stable and non-hygroscopic salts of L-carnitine magnesium tartrate or lower alkanoyl-L-carnitine magnesium tartrate, of formula (I), are suitable for preparing solid compositions useful as dietary or nutritional supplements for human use and as a fodder supplement for veterinary purposes. In formula (I), R is selected from the group comprising acetyl, propionyl, butyryl, valeryl and isovaleryl.
Patent NZ-506544-A (NZ)
Title: DNA sequences from Lactococcus lactis strain FL877 containing natural conjugative genes which is capable of passing genetic material from two cells in contact with each other
Inventor: PREVOTS FABIEN
IPC: C12N15/31
Filed: 1999-12-28
Abstract: The present invention relates to an adjuvant composition comprising a polyoxyethylene ether or a polyoxyethylene ester, in combination with a pharmaceutically acceptable excipient, and to a vaccine comprising such adjuvant compositions and antigen. In addition, the present invention relates to the use of polyoxyethylene ethers or esters in the manufacture of adjuvant formulations, and vaccine formulations, and their use as medicaments.
Patent NZ-513107-A (NZ)
Title: Full body atomised bath and method for providing a full body atomised bath
Inventor: BUSSELMANN MANFRED
IPC: B05B1/18
Filed: 1999-12-16
Abstract: A method for administering a full-body mist bath, as well as a full-body mist-bath unit, having a bathing cubicle for accommodating at least one person and atomised liquid. A liquid atomiser is provided with a high-pressure chamber in which the liquid is compressed by the action of a high pressure to prepare the atomised liquid. A nozzle is provided for explosive ejection of the compressed liquid subjected to high pressure, so that it bursts apart into small particles. In the process, the particles become positively charged and their photon emission is increased.
Patent NZ-516329-A (NZ)
Title: Method of packing products where information about a characteristic of the product is acquired and used to pack the product
Inventor: KOKE JOHN PAUL
IPC: B65B59/02
Filed: 2001-12-21
Abstract: Method and Apparatus for automated packing of products including: a product information acquisition stage arranged to acquire information relating to the shape or at least width and height of individual products on a product packing line, a pack supply system arranged to supply packs sequentially as individual products approach the packing apparatus on a conveyor, a pack opener arranged to automatedly take up a pack from the pack supply system as each individual product approaches the pack opener, and to subsequently machine open a mouth of each pack to a variable extent of lift in a direction at approximately right angles to a major plane of the unopened pack and to a variable degree of width opening in a direction approximately in a major plane of the unopened pack, based on information relating to the shape or at least height and width of the product acquired at the upstream product information acquisition stage.